Healthcare
Trethera
Recorded October 14, 2026
A first-in-class oral therapy for cancer, neuroinflammatory, and autoimmune disease with both FDA Fast Track and Orphan Drug designations
A first-in-class oral therapy for cancer, neuroinflammatory, and autoimmune disease with both FDA Fast Track and Orphan Drug designations
Kesmalea is developing an oral therapeutic designed to selectively eliminate a protein strongly associated with Alzheimer’s progression
How leading scientists determine which discoveries have the potential to become meaningful new therapies.
NIMA has developed a handheld sensor that can test a food sample for gluten contamination in approximately three minutes with 99% accuracy.
SonicTrek uses AI to make radio more local by delivering customized programming, localized on-air content, and market-specific personalities at a fraction of the cost
PortIO is the first intraosseous port that provides long-term vascular access, maintenance-free operation, fewer infections, and broad clinical applicability
Vessel Wave is fixing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
A proven, proprietary, scalable technology for converting organic waste into the building blocks of Sustainable Aviation Fuel
Trethera targets an enzyme that is highly active across many solid tumors, autoimmune diseases, and inflammatory disorders
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure